SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 102 filers reported holding SCICLONE PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $4,460,000 | +1.4% | 400,000 | 0.0% | 0.09% | -2.3% |
Q2 2017 | $4,400,000 | +534.9% | 400,000 | +523.8% | 0.09% | +252.0% |
Q4 2016 | $693,000 | -81.6% | 64,127 | -82.6% | 0.02% | -78.4% |
Q3 2016 | $3,770,000 | +8.5% | 367,800 | +38.3% | 0.12% | +1.8% |
Q2 2016 | $3,474,000 | +0.7% | 265,971 | -15.2% | 0.11% | +15.2% |
Q1 2016 | $3,450,000 | +31.6% | 313,637 | +10.2% | 0.10% | +59.7% |
Q4 2015 | $2,621,000 | +144.7% | 284,545 | +84.5% | 0.06% | +82.4% |
Q3 2015 | $1,071,000 | -69.9% | 154,266 | -57.5% | 0.03% | -64.9% |
Q2 2015 | $3,564,000 | -5.9% | 362,898 | -15.1% | 0.10% | +1.0% |
Q1 2015 | $3,787,000 | -28.9% | 427,472 | -29.0% | 0.10% | -17.9% |
Q4 2014 | $5,328,000 | +8.5% | 601,891 | -15.4% | 0.12% | +4.5% |
Q3 2014 | $4,911,000 | +340.1% | 711,369 | +221.3% | 0.11% | +300.0% |
Q4 2013 | $1,116,000 | -35.7% | 221,369 | -35.3% | 0.03% | -28.2% |
Q3 2013 | $1,735,000 | +325.2% | 342,136 | +316.0% | 0.04% | +254.5% |
Q2 2013 | $408,000 | – | 82,251 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Athos Capital Ltd | 410,389 | $4,596,000 | 3.46% |
GLG Partners LP | 2,586,437 | $28,968,000 | 1.54% |
Nine Chapters Capital Management LLC | 32,300 | $362,000 | 0.80% |
FNY Partners Fund LP | 335,900 | $3,762,000 | 0.64% |
MENTA CAPITAL LLC | 373,523 | $4,183,000 | 0.61% |
Yakira Capital Management, Inc. | 85,500 | $958,000 | 0.32% |
Sapphire Star Partners LP | 18,724 | $209,000 | 0.27% |
GAM Holding AG | 541,025 | $6,059,000 | 0.26% |
Bowling Portfolio Management LLC | 127,873 | $1,432,000 | 0.22% |
Kassirer Asset Management Corp | 15,000 | $168,000 | 0.16% |